Home Supplements How We Rate Blog
D-Ribose

Ribose

Research reviewed: Up until 03/2026

Ribose (D-Ribose) is a dietary supplement with 9 published peer-reviewed studies involving 368 participants, researched for Chronic Fatigue & Fibromyalgia, Cardiac Function, Energy Metabolism and 1 more areas.

9
Studies
368
Participants
1991–2022
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Strong Evidence

Chronic Fatigue & Fibromyalgia

Moderate
3 studies 2 of 3 positive 298 participants 2 human

Cardiac Function

Moderate
2 studies 1 of 2 positive 20 participants 1 human

Energy Metabolism

Moderate
3 studies 0 of 3 positive 50 participants 2 human

Energy Metabolism & NAD+

Moderate
1 study 0 of 1 positive 0 participants

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

4/9
Randomised
1/9
Double-Blind
2/9
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (2006)
41
Study 2 (2012)
257
Study 3 (2012)
0
Study 4 (2003)
20
Study 5 (1991)
0
Study 6 (1993)
26
Study 7 (2020)
24
Study 8 (2004)
0

Research Timeline

When the studies were published

1
1991
1
1993
1
2003
1
2004
1
2006
2
2012
1
2020
1
2022

All Studies

Detailed breakdown of each trial. Click to expand.

Chronic Fatigue & Fibromyalgia

1

To assess D-ribose on energy and well-being in CFS and fibromyalgia

2006 41 participants Average 3 weeks 5 g three times daily
Human Study Positive

Study Type

Pilot open-label study

Purpose

To assess D-ribose on energy and well-being in CFS and fibromyalgia

Dose

5 g three times daily

Participants

41 patients with CFS and fibromyalgia

Duration

Average 3 weeks

Results

66% experienced significant improvement. Average VAS energy increase of 45%, overall well-being improvement of 30% (p<0.0001). PMID: 17109576

How They Measured It

VAS energy, sleep, mental clarity, pain, well-being

Read full study
2

To assess D-ribose treatment of CFS and fibromyalgia

2012 257 participants 3 weeks 5 g three times daily
Human Study Positive

Study Type

Open-label multicentre study

Purpose

To assess D-ribose treatment of CFS and fibromyalgia

Dose

5 g three times daily

Participants

257 patients across multiple centres

Duration

3 weeks

Results

D-ribose supplementation significantly improved all FIBRO parameters. 53.6% showed meaningful improvement. Average energy increase 61.3% over baseline. PMID: 19641697

How They Measured It

FIBRO score (energy, sleep, mental clarity, pain, overall well-being)

Read full study
3

To review D-ribose role in ATP resynthesis and cellular energy deficiency states

2012 ? participants N/A Various
Review/Other Mixed

Study Type

Review

Purpose

To review D-ribose role in ATP resynthesis and cellular energy deficiency states

Dose

Various

Participants

N/A

Duration

N/A

Results

D-ribose is essential for ATP and NAD+ synthesis via pentose phosphate pathway. In energy-deficient states like CFS and fibromyalgia, supplemental ribose restores cellular energy more rapidly than the body can synthesize it.

How They Measured It

Biochemical and clinical literature review

Read full study

Cardiac Function

4

To assess D-ribose on cardiac function and exercise tolerance in chronic heart failure

2003 20 participants 6 weeks 15 g/day D-ribose
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised double-blind placebo-controlled

Purpose

To assess D-ribose on cardiac function and exercise tolerance in chronic heart failure

Dose

15 g/day D-ribose

Participants

20 CHF patients (NYHA III)

Duration

6 weeks

Results

D-ribose significantly improved diastolic dysfunction indices, increased 6-minute walk distance, and improved quality of life in heart failure patients vs placebo. PMID: 12510799

How They Measured It

LVEF, 6-minute walk test, diastolic function, quality of life

Read full study
5

To assess D-ribose on ATP recovery after cardiac ischemia

1991 ? participants Perioperative 1 mg/kg D-ribose IV
Animal Study Positive

Study Type

Animal study

Purpose

To assess D-ribose on ATP recovery after cardiac ischemia

Dose

1 mg/kg D-ribose IV

Participants

Dogs with experimental cardiac ischemia

Duration

Perioperative

Results

D-ribose administration significantly accelerated ATP recovery in post-ischemic myocardium and improved cardiac function recovery after ischemia-reperfusion. PMID: 1712754

How They Measured It

Myocardial ATP content, cardiac function, recovery time

Read full study

Energy Metabolism

6

To assess D-ribose on exercise capacity and muscle ATP recovery

1993 26 participants 2 weeks 3-4 g/day oral D-ribose
Human Study RCT Mixed

Study Type

Randomised controlled trial

Purpose

To assess D-ribose on exercise capacity and muscle ATP recovery

Dose

3-4 g/day oral D-ribose

Participants

26 healthy trained subjects

Duration

2 weeks

Results

D-ribose supplementation enhanced muscle ATP recovery after high-intensity exercise and improved endurance performance vs placebo. PMID: 8429047

How They Measured It

Muscle ATP, exercise time to exhaustion, lactate

Read full study
7

To evaluate D-ribose on endurance performance in trained cyclists

2020 24 participants 4 weeks 3 g before and after exercise
Human Study RCT Positive

Study Type

Randomised controlled trial

Purpose

To evaluate D-ribose on endurance performance in trained cyclists

Dose

3 g before and after exercise

Participants

24 trained cyclists

Duration

4 weeks

Results

D-ribose supplementation showed non-significant trend for improved time trial performance. More benefit observed in high-intensity protocols requiring rapid ATP turnover.

How They Measured It

Time trial performance, power output, VO2max

Read full study
8

To investigate D-ribose on NAD+ biosynthesis and cellular energy pathways

2004 ? participants N/A Various concentrations
In Vitro Positive

Study Type

In vitro study

Purpose

To investigate D-ribose on NAD+ biosynthesis and cellular energy pathways

Dose

Various concentrations

Participants

Cardiac and skeletal muscle cell cultures

Duration

N/A

Results

D-ribose provided as substrate significantly accelerated NAD+ and ATP biosynthesis via the pentose phosphate pathway, restoring cellular energetics more rapidly than de novo synthesis. PMID: 15451954

How They Measured It

Pentose phosphate pathway flux, NAD+/NADH, ATP levels

Read full study

Energy Metabolism & NAD+

9

To evaluate whether a combination of nicotinamide and D-ribose increases NAD+ metabolism in healthy middle-aged adults.

2022 ? participants 4 weeks Nicotinamide 215 mg plus D-ribose 3.0 g daily
Human Study RCT Placebo Mixed

Study Type

Randomized, Triple-Blind, Placebo-Controlled Crossover

Purpose

To evaluate whether a combination of nicotinamide and D-ribose increases NAD+ metabolism in healthy middle-aged adults.

Dose

Nicotinamide 215 mg plus D-ribose 3.0 g daily

Participants

Healthy middle-aged adults

Duration

4 weeks

Results

The combination of nicotinamide and D-ribose (RiaGev) was safe and effective at increasing NAD+ metabolome in healthy middle-aged adults.

How They Measured It

NAD+ metabolome markers (NMN, NAD+, NADH), blood metabolomics

Read full study

Frequently Asked Questions

Common questions about Ribose research

What does the research say about Ribose?

There are currently 9 peer-reviewed studies on Ribose (D-Ribose), involving 368 total participants. Research covers Energy metabolism, Chronic fatigue & fibromyalgia, Cardiac function. The overall evidence strength is rated as Strong.

How strong is the evidence for Ribose?

The evidence is currently rated as "Strong Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (6 human studies, 1 animal study), and reported outcomes.

What health goals has Ribose been studied for?

Ribose has been researched for: Energy metabolism, Chronic fatigue & fibromyalgia, Cardiac function. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on Ribose based on human trials?

Yes, 6 out of 9 studies are human trials. The remaining 1 is an animal study. Human trials carry more weight in our evidence scoring system.